Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
116192023 | 11619202 | 3 | F | 2009 | 20160802 | 20151012 | 20160815 | PER | US-BAYER-2015-435890 | BAYER | 0.00 | E | M | Y | 88.44000 | KG | 20160815 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
116192023 | 11619202 | 1 | PS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | UNK | 19537 | TABLET | ||||||||||
116192023 | 11619202 | 2 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | 500 MG, BID | 0 | 500 | MG | BID | ||||||||
116192023 | 11619202 | 3 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | 500 MG, BID | 0 | 500 | MG | BID | ||||||||
116192023 | 11619202 | 4 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | 250 MG, BID | 0 | 250 | MG | BID | ||||||||
116192023 | 11619202 | 5 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | 500 MG, BID | 0 | 500 | MG | BID | ||||||||
116192023 | 11619202 | 6 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | 500 MG, BID | 0 | 500 | MG | BID | ||||||||
116192023 | 11619202 | 7 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | 750 MG, UNK | 0 | 750 | MG | |||||||||
116192023 | 11619202 | 8 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | 500 MG, BID | 0 | 500 | MG | BID | ||||||||
116192023 | 11619202 | 9 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | 500 MG, UNK | 0 | 500 | MG | ||||||||
116192023 | 11619202 | 10 | SS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | 0 | FILM-COATED TABLET | |||||||||||
116192023 | 11619202 | 11 | SS | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | 500 MG, QD | 0 | 500 | MG | QD | ||||||||
116192023 | 11619202 | 12 | SS | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Oral | 500 MG, QD | 0 | 500 | MG | QD | |||||||
116192023 | 11619202 | 13 | C | LACTULOSE. | LACTULOSE | 1 | 30 ML, BID | 0 | 30 | ML | BID | ||||||||
116192023 | 11619202 | 14 | C | BISACODYL. | BISACODYL | 1 | UNK | 0 | |||||||||||
116192023 | 11619202 | 15 | C | LORAZEPAM. | LORAZEPAM | 1 | 1 PILL 2X/DAY AS NEEDED | 0 | |||||||||||
116192023 | 11619202 | 16 | C | LORAZEPAM. | LORAZEPAM | 1 | 2 MG, UNK | 0 | 2 | MG | |||||||||
116192023 | 11619202 | 17 | C | LOSARTAN. | LOSARTAN | 1 | 100 MG, QD | 0 | 100 | MG | QD | ||||||||
116192023 | 11619202 | 18 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | 100 MCG/24HR, UNK | 0 | |||||||||||
116192023 | 11619202 | 19 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | 1.000 MCG/L, UNK | 0 | |||||||||||
116192023 | 11619202 | 20 | C | GABAPENTIN. | GABAPENTIN | 1 | 100 MG, UNK | 0 | 100 | MG | |||||||||
116192023 | 11619202 | 21 | C | CEPHALEXIN. | CEPHALEXIN | 1 | Oral | 250 MG, UNK | 0 | 250 | MG | ||||||||
116192023 | 11619202 | 22 | C | DOXYCYCLINE MONOHYDRATE [DOXYCYCLINE] | 2 | UNK UNK, BID | 0 | BID | |||||||||||
116192023 | 11619202 | 23 | C | CLONIDINE HYDROCHLORIDE. | CLONIDINE HYDROCHLORIDE | 1 | UNK UNK, BID | 0 | BID | ||||||||||
116192023 | 11619202 | 24 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | 25 MG, TID | 0 | 25 | MG | TID | ||||||||
116192023 | 11619202 | 25 | C | ATROVENT | IPRATROPIUM BROMIDE | 1 | UNK UNK, PRN | 0 | |||||||||||
116192023 | 11619202 | 26 | C | ALBUTEROL. | ALBUTEROL | 1 | UNK UNK, QID | 0 | QID | ||||||||||
116192023 | 11619202 | 27 | C | ALBUTEROL. | ALBUTEROL | 1 | 90 MCG/ACTUATION | 0 | |||||||||||
116192023 | 11619202 | 28 | C | BENEFIBER | STARCH, WHEAT | 1 | 10 ML, TID | 0 | 10 | ML | TID | ||||||||
116192023 | 11619202 | 29 | C | ATENOLOL. | ATENOLOL | 1 | UNK UNK, BID | 0 | BID | ||||||||||
116192023 | 11619202 | 30 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 10 MG, QD | 0 | 10 | MG | QD | ||||||||
116192023 | 11619202 | 31 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 20 MG, UNK | 0 | 20 | MG | ||||||||
116192023 | 11619202 | 32 | C | TRAMADOL. | TRAMADOL | 1 | 2X/DAY AS NEEDED | 0 | |||||||||||
116192023 | 11619202 | 33 | C | FLUTICASONE W/SALMETEROL | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 500-50 MCG/DOSE | 0 | ||||||||||
116192023 | 11619202 | 34 | C | FELODIPINE. | FELODIPINE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
116192023 | 11619202 | 35 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Oral | 10 MG, UNK | 0 | 10 | MG | ||||||||
116192023 | 11619202 | 36 | C | CLOBETASOL | CLOBETASOL | 1 | Topical | 0.05 %, UNK | 0 | .05 | PCT | ||||||||
116192023 | 11619202 | 37 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 40 MG, UNK | 0 | 40 | MG | ||||||||
116192023 | 11619202 | 38 | C | TIOTROPIUM | TIOTROPIUM | 1 | Respiratory (inhalation) | 18 MCG | 0 | ||||||||||
116192023 | 11619202 | 39 | C | FENOFIBRATE. | FENOFIBRATE | 1 | Oral | 160 MG, UNK | 0 | 160 | MG | ||||||||
116192023 | 11619202 | 40 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Oral | 500 MG, UNK | 0 | 500 | MG | ||||||||
116192023 | 11619202 | 41 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 10 MG, UNK | 0 | 10 | MG | ||||||||
116192023 | 11619202 | 42 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
116192023 | 11619202 | 43 | C | DULCOLAX (BISACODYL) | BISACODYL | 1 | UNK | 0 | |||||||||||
116192023 | 11619202 | 44 | C | FLAGYL | METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE | 1 | 500 MG/100ML | 0 | |||||||||||
116192023 | 11619202 | 45 | C | LEVAQUIN | LEVOFLOXACIN | 1 | 500 MG/100 ML IV | 0 | |||||||||||
116192023 | 11619202 | 46 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | UNK | 0 | |||||||||||
116192023 | 11619202 | 47 | C | PULMICORT RESPULES | BUDESONIDE | 1 | UNK | 0 | |||||||||||
116192023 | 11619202 | 48 | C | REGLAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
116192023 | 11619202 | 49 | C | SODIUM CHLORIDE. | SODIUM CHLORIDE | 1 | 0.9 %, UNK | 0 | .9 | PCT | |||||||||
116192023 | 11619202 | 50 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
116192023 | 11619202 | 51 | C | TYLENOL | ACETAMINOPHEN | 1 | UNK | 0 | |||||||||||
116192023 | 11619202 | 52 | C | CLONIDINE. | CLONIDINE | 1 | UNK | 0 | |||||||||||
116192023 | 11619202 | 53 | C | GLUCAGON. | GLUCAGON | 1 | UNK | 0 | |||||||||||
116192023 | 11619202 | 54 | C | HEPARIN | HEPARIN SODIUM | 1 | UNK | 0 | |||||||||||
116192023 | 11619202 | 55 | C | IPRATROPIUM | IPRATROPIUM | 1 | UNK | 0 | |||||||||||
116192023 | 11619202 | 56 | C | LACTOBACILLUS ACIDOPHILUS | LACTOBACILLUS ACIDOPHILUS | 1 | UNK | 0 | |||||||||||
116192023 | 11619202 | 57 | C | VANCOMYCIN | VANCOMYCIN | 1 | UNK | 0 | |||||||||||
116192023 | 11619202 | 58 | C | MEROPENEM. | MEROPENEM | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
116192023 | 11619202 | 2 | Lung infection |
116192023 | 11619202 | 3 | Lung infection |
116192023 | 11619202 | 4 | Lung infection |
116192023 | 11619202 | 5 | Lung infection |
116192023 | 11619202 | 6 | Lung infection |
116192023 | 11619202 | 7 | Lung infection |
116192023 | 11619202 | 8 | Lung infection |
116192023 | 11619202 | 9 | Lung infection |
116192023 | 11619202 | 11 | Lung infection |
116192023 | 11619202 | 12 | Lung infection |
116192023 | 11619202 | 13 | Constipation |
116192023 | 11619202 | 14 | Constipation |
116192023 | 11619202 | 15 | Anxiety |
116192023 | 11619202 | 16 | Insomnia |
116192023 | 11619202 | 17 | Hypertension |
116192023 | 11619202 | 18 | Hypovitaminosis |
116192023 | 11619202 | 19 | Hypovitaminosis |
116192023 | 11619202 | 20 | Neuropathy peripheral |
116192023 | 11619202 | 21 | Lung infection |
116192023 | 11619202 | 22 | Lung infection |
116192023 | 11619202 | 23 | Hypertension |
116192023 | 11619202 | 24 | Hypertension |
116192023 | 11619202 | 26 | Dyspnoea |
116192023 | 11619202 | 27 | Dyspnoea |
116192023 | 11619202 | 28 | Nutritional supplementation |
116192023 | 11619202 | 29 | Hypertension |
116192023 | 11619202 | 30 | Blood cholesterol abnormal |
116192023 | 11619202 | 31 | Blood cholesterol abnormal |
116192023 | 11619202 | 32 | Pain |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
116192023 | 11619202 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
116192023 | 11619202 | Anxiety | |
116192023 | 11619202 | Balance disorder | |
116192023 | 11619202 | Cardiovascular disorder | |
116192023 | 11619202 | Depression | |
116192023 | 11619202 | Emotional distress | |
116192023 | 11619202 | Hypoaesthesia | |
116192023 | 11619202 | Injury | |
116192023 | 11619202 | Mental disorder | |
116192023 | 11619202 | Musculoskeletal injury | |
116192023 | 11619202 | Nervous system disorder | |
116192023 | 11619202 | Neuropathy peripheral | |
116192023 | 11619202 | Pain | |
116192023 | 11619202 | Paraesthesia | |
116192023 | 11619202 | Skin injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
116192023 | 11619202 | 2 | 20110211 | 20111007 | 0 | |
116192023 | 11619202 | 3 | 20120228 | 20120313 | 0 | |
116192023 | 11619202 | 4 | 20120618 | 20120709 | 0 | |
116192023 | 11619202 | 5 | 20120813 | 20120910 | 0 | |
116192023 | 11619202 | 6 | 20130503 | 20130531 | 0 | |
116192023 | 11619202 | 7 | 20131007 | 20131017 | 0 | |
116192023 | 11619202 | 8 | 20131002 | 20131005 | 0 | |
116192023 | 11619202 | 9 | 20141006 | 20141009 | 0 | |
116192023 | 11619202 | 11 | 20120708 | 20120723 | 0 | |
116192023 | 11619202 | 12 | 20131206 | 20131217 | 0 | |
116192023 | 11619202 | 29 | 2006 | 0 | ||
116192023 | 11619202 | 30 | 2011 | 0 | ||
116192023 | 11619202 | 32 | 2015 | 0 | ||
116192023 | 11619202 | 58 | 20130702 | 0 |